Dr Curtis P Swagler, DO | |
Eisenhower Drive, Rm 422 Student Health Center, University Park, PA 16802 | |
(814) 863-6747 | |
(814) 863-8464 |
Full Name | Dr Curtis P Swagler |
---|---|
Gender | Male |
Speciality | General Practice |
Location | Eisenhower Drive, University Park, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306859475 | NPI | - | NPPES |
000745495 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | OS-004172L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Curtis P Swagler, DO Eisenhower Drive, Rm 422 Student Health Center, University Park, PA 16802 Ph: (814) 863-6747 | Dr Curtis P Swagler, DO Eisenhower Drive, Rm 422 Student Health Center, University Park, PA 16802 Ph: (814) 863-6747 |
News Archive
Oral cancer is the 6th most common cancer in men and the 14th most common cancer in women. In the US, oral cancer will be diagnosed in an estimated 30,000 Americans this year and will cause more than 8,000 deaths.
AMN Healthcare Services, Inc. announced it has completed the sale of its home healthcare business to BAYADA Home Health Care, Inc. effective January 30, 2012. As a result of the sale, AMN will receive cash proceeds of $9.65 million and retain working capital of approximately $4 million.
"Just two years ago, our country had one of the worst maternal and infant death rates in the world," Sierra Leone President Ernest Bai Koroma writes in a Huffington Post U.K. "Impact" blog post, adding, "We knew something had to be done." So in September 2009, the government announced "that all health user fees would be removed for pregnant and lactating women and children under the age of five" and "introduced the Free Health Care Initiative [FHCI] in April 2010, which would give around 460,000 women and a million children a much better chance of having a longer and happier life," Koroma writes.
The gene therapy market has had limited success with products during the clinical development process. Due to toxicological complications and poor therapy efficacy, healthcare authorities have suspended several gene therapy trials worldwide.
Silent ischemic lesions are common and are associated with a high rate of recurrent events in young patients with acute ischemic stroke, report researchers.
› Verified 3 days ago